Canada markets open in 1 hour 6 minutes

Graybug Vision, Inc. (GRAY)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.8500-0.0120 (-1.39%)
At close: 04:00PM EDT
Sign in to post a message.
  • S
    SuperEagle2000
    the CEO and the rest of their leadership team did not buy one single share of their own company on the open market during the last 18 month,
    the CEO milked $4.4 million out of the company in 2021 but he did not spend one single Dollar of his gigantic salary on shares at these sellout price levels,
    how should anybody have confidence in this leadership team ?
  • B
    Butterscotch 3000
    If you're down on GRAY (and who isn't if you bought in the past year+ and held until now...?), the time to average down is now.

    Better yet, if you're a new buyer, the time to buy is now!

    I expect GRAY is about to see a big jump in the PPS; similar to what occurred when $CLDX, $OCGN and $BNGO; etc. experienced when they saw their big bounces.

    Low price, low cap, no debt and trading at a third of cash on hand.

    Big money is about to run this stock back up!

    You'll see...
  • m
    michelle
    From $35 to $1.....
  • m
    michelle
    Dead company.
  • A
    Anti
    Gray will not turn until the XBI stops dropping. Worst sector I've seen in a long time. But the CEO has some gall to bump his pay after this dismal stock performance. And again; the SEC is MIA.
  • c
    cd
    Sell the asset and return the capital. Won't do it but that would send a message.
  • T
    TruckingAngler
    GRAY 4/27/2022: Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meeting May 1-4, 2022.
    " Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today announced a poster presentation of preclinical data for GB-401 in primary open-angle glaucoma (POAG) at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, to be held at the Colorado Convention Center in Denver from May 1-4, 2022.

    Information is listed below and available on the ARVO website.
    In Vitro and In Vivo Characterizations of GB-401, a Sustained-Release Intravitreal Implant Containing a Beta-Adrenergic Antagonist Prodrug for POAG
    Presenter: Yun Yu, PhD, Associate Director R&D, Graybug Vision
    Poster Session: Drug Delivery
    Date and Time: Wednesday May 4, 2022; 12:30 – 2:30 PM MT (2:30 – 4:30 PM ET). Location: Poster Hall - F0151 "
  • m
    michelle
    Is there any hope left for this company. Embarrassing!
  • S
    SuperEagle2000
    more than embarrassing,
    the CEO received a salary of $4,4 million last year, thats about 20 % of the companys market cap,
    he and the other officers did not buy one single share of their own company on the open market,
    thats all you have to know
  • B
    Bechody
    This will end just like BBI. DO NOT HOLD!
  • m
    michelle
    Fire the CEO, CFO, and bring in someone who knows how to run this company properly. Embarrassing to watch!
  • S
    SuperEagle2000
    Leerink Partners analyst Marc Goodman maintained a Hold rating on Graybug Vision on March 30 and set a price target of $5.00.
  • m
    michelle
    New ceo please.....
  • A
    Anti
    Current MC of 20 million?? Sure, why not? Bankruptcy just around the corner with 60 million in cash, right?
  • m
    michelle
    Delisting notice very soon.
  • T
    TruckingAngler
    GRAY 3/17/2022 target $4...
    Cantor Fitzgerald analyst Jennifer Kim maintains Graybug Vision (NASDAQ:GRAY) lowers price target from $6 to $4.
    The analyst firm set a price target for $4.00 expecting GRAY to rise to within 12 months (a possible 179.72% upside). 3 analyst firms have reported ratings in the last year.
    GLTA
  • m
    michelle
    Graybug Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023
  • Y
    Yahoo Finance Insights
    Graybug Vision is down 9.42% to 0.82
  • m
    michelle
    Last January, this was trading at $35 pps. God I wish we could see that again!!
  • Y
    Yahoo Finance Insights
    Graybug Vision is down 8.83% to 0.95